1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Population-based study of patients with primary Sjögren’s syndrome and lymphoma : lymphoma subtypes, clinical characteristics, and gender differences
- 2019
- Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjögren’s syndrome
- 2011
-
Pediatric organ transplantation and risk of premalignant and malignant tumors in Sweden
Simard, J F ; Baecklund, E ; Kinch, A ; Brattström, C ; Ingvar, A LU
; Molin, D
; Adami, J
; Fernberg, P
; Wilczek, H
and Ekbom, A
, et al.
(2011)
In American Journal of Transplantation
11(1).
p.51-146
Mark
-
Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients
Fernberg, P ; Edgren, G ; Adami, J ; Ingvar, A LU
; Bellocco, R
; Tufveson, G
; Höglund, P
; Kinch, A
; Simard, J F
and Baecklund, E
, et al.
(2011)
In American Journal of Transplantation
11(11).
p.82-2472
Mark
- Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjogren's syndrome
- 2009
- Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas:relative risks and time-trends in the Swedish Biologics Register
- 2005
- Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
- Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
- Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists